Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 60 (2) , 444-452
- https://doi.org/10.1016/j.ijrobp.2004.03.026
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head regionCancer, 1995
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Pylorus-Preserving PancreatoduodenectomyArchives of Surgery, 1994
- Resection Margins in Carcinoma of the Head of the PancreasAnnals of Surgery, 1993
- Prognostic indicators for survival after resection of pancreatic adenocarcinomaThe American Journal of Surgery, 1993
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomasBritish Journal of Surgery, 1992
- Factors influencing survival after pancreaticoduodenectomy for pancreatic cancerThe American Journal of Surgery, 1991
- Survival After PancreatoduodenectomyAnnals of Surgery, 1990